Immucell Corp (ICCC)

$6.24 +0.24 (4.08%)
Market Cap 54.22M
Revenue (ttm) 26.49M
Net Income (ttm) -2.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8.15%
Debt to Equity Ratio 0.35
Volume 2,578
Avg Vol 29,952
Day's Range N/A - N/A
Shares Out 9.04M
Stochastic %K 1%
Beta 0.30
Analysts Strong Buy
Price Target $14.00

Company Profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus...

Industry: Biotechnology
Sector: Healthcare
Phone: 207 878 2770
Address:
56 Evergreen Drive, Portland, United States
TommyTwenty
TommyTwenty Jul. 29 at 7:04 PM
$ICCC old article I found. https://www.mainebiz.biz/article/an-industry-with-a-family-tree-much-of-maines-biotech-industry-grew-out-of-two-firms
0 · Reply
TommyTwenty
TommyTwenty Jul. 29 at 11:58 AM
$ICCC
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 7:35 PM
$ICCC Outstanding article that hits the mark on ICCC's current state. So if you want to refresh your ICCC insights or learn about ICCC from scratch, this is a must read. https://beyondspx.com/article/immucell-riding-operational-recovery-and-novel-technology-towards-profitability-iccc
0 · Reply
TagUrIt
TagUrIt Jul. 25 at 1:28 PM
$ICCC well the Zach’s announcement should help with the companies visibility…
1 · Reply
ZacksResearch
ZacksResearch Jul. 22 at 5:58 PM
$ICCC just got a major upgrade — here's why the bulls are circling 🐂 Q1 sales hit record highs, margins expanded, and Re-Tain’s FDA momentum plus new formats are fueling serious upside potential. Full breakdown of the upgrade here 👉 https://www.zacks.com/stock/news/2604144/immucell-upgraded-to-outperform-on-sales-surge-fda-upside?cid=sm-stocktwits-2-2604144-teaser-3177&ADID=SYND_STOCKTWITS_TWEET_2_2604144_TEASER_3177
0 · Reply
ZacksResearch
ZacksResearch Jul. 22 at 3:56 PM
$ICCC up 64.3% in a year — what's driving the surge? 🚀 📈 Record Q1 sales of $8.1M, up 11% YoY, fueled by strong First Defense demand. 📊 Gross margin jumped to 42% from 32% a year ago, boosting cash flow and liquidity. 🔍 New bulk powder format and the potential of Re-Tain under FDA review offer strategic growth opportunities. See what makes the investment case strong for ImmuCell 👉 https://www.zacks.com/stock/news/2604144/immucell-upgraded-to-outperform-on-sales-surge-fda-upside?cid=sm-stocktwits-2-2604144-body-3098&ADID=SYND_STOCKTWITS_TWEET_2_2604144_BODY_3098
0 · Reply
TommyTwenty
TommyTwenty Jul. 9 at 2:47 PM
$ICCC looks they’re initiating expansion from 30 mill to 40 mill.
0 · Reply
TommyTwenty
TommyTwenty Jul. 9 at 1:13 PM
$ICCC backlog has been reduced to under 100k.
0 · Reply
theRooster007
theRooster007 Jul. 9 at 12:41 PM
$ICCC https://lifesciencereport.com/news/nasdaq/iccc/immucell-announces-preliminary-unaudited-sales-results-for-q2-of-2025
0 · Reply
DARKP00L
DARKP00L Jul. 9 at 12:13 PM
$ICCC 08:11 on Jul. 09 2025 ImmuCell Announces Prelim. Q2 Sales $6.4M, Up 18% YoY #tradeideas
0 · Reply
Latest News on ICCC
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

Jul 9, 2025, 8:00 AM EDT - 26 days ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025

ImmuCell Embarks on CEO Succession Planning Process

Jun 25, 2025, 8:00 AM EDT - 5 weeks ago

ImmuCell Embarks on CEO Succession Planning Process

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

Jun 5, 2025, 6:30 AM EDT - 2 months ago

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript

May 15, 2025, 10:19 AM EDT - 2 months ago

ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025

May 14, 2025, 4:05 PM EDT - 2 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

May 12, 2025, 8:42 AM EDT - 3 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

Apr 8, 2025, 4:05 PM EDT - 4 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

Apr 2, 2025, 4:05 PM EDT - 4 months ago

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®

ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 11:44 AM EST - 5 months ago

ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Feb 25, 2025, 4:05 PM EST - 5 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

Feb 20, 2025, 8:19 AM EST - 5 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses

Jan 16, 2025, 4:05 PM EST - 7 months ago

ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024

Jan 9, 2025, 4:05 PM EST - 7 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024

ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:09 AM EST - 9 months ago

ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024

Nov 13, 2024, 4:05 PM EST - 9 months ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

Nov 7, 2024, 8:30 AM EST - 9 months ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

Oct 8, 2024, 4:05 PM EDT - 10 months ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 12:18 PM EDT - 1 year ago

ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

Aug 13, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024

Aug 7, 2024, 4:05 PM EDT - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

Jul 9, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®

Jun 5, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®

ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

May 15, 2024, 1:48 PM EDT - 1 year ago

ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

May 14, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

May 8, 2024, 1:00 PM EDT - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

Apr 9, 2024, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 11:58 AM EST - 1 year ago

ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Feb 27, 2024, 4:05 PM EST - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Feb 16, 2024, 9:30 AM EST - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

Jan 8, 2024, 4:05 PM EST - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 2:36 PM EST - 1 year ago

ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

Nov 13, 2023, 4:05 PM EST - 1 year ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

Nov 7, 2023, 12:15 PM EST - 1 year ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023

Oct 5, 2023, 4:05 PM EDT - 1 year ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023

ImmuCell Announces Submission of CMC Technical Section to the FDA

Aug 29, 2023, 8:00 AM EDT - 2 years ago

ImmuCell Announces Submission of CMC Technical Section to the FDA

ImmuCell Corporation (ICCC) Q2 2023 Earnings Call Transcript

Aug 11, 2023, 4:48 PM EDT - 2 years ago

ImmuCell Corporation (ICCC) Q2 2023 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023

Aug 10, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023

Aug 7, 2023, 12:00 PM EDT - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023

Jul 11, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023

ImmuCell Announces Change in Timing of Anticipated FDA Submission

Jun 28, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Change in Timing of Anticipated FDA Submission

ImmuCell Appoints Bryan K. Gathagan to Board of Directors

Jun 21, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Appoints Bryan K. Gathagan to Board of Directors

ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility

Jun 15, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility

ImmuCell Corporation (ICCC) Q1 2023 Earnings Call Transcript

May 12, 2023, 10:00 AM EDT - 2 years ago

ImmuCell Corporation (ICCC) Q1 2023 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

May 11, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023

May 4, 2023, 6:30 AM EDT - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023

Apr 5, 2023, 4:05 PM EDT - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023

ImmuCell Corporation (ICCC) Q4 2022 Earnings Call Transcript

Feb 22, 2023, 12:50 PM EST - 2 years ago

ImmuCell Corporation (ICCC) Q4 2022 Earnings Call Transcript

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022

Feb 21, 2023, 4:05 PM EST - 2 years ago

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022

Feb 15, 2023, 11:55 AM EST - 2 years ago

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022

Jan 9, 2023, 4:05 PM EST - 2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022

TommyTwenty
TommyTwenty Jul. 29 at 7:04 PM
$ICCC old article I found. https://www.mainebiz.biz/article/an-industry-with-a-family-tree-much-of-maines-biotech-industry-grew-out-of-two-firms
0 · Reply
TommyTwenty
TommyTwenty Jul. 29 at 11:58 AM
$ICCC
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 7:35 PM
$ICCC Outstanding article that hits the mark on ICCC's current state. So if you want to refresh your ICCC insights or learn about ICCC from scratch, this is a must read. https://beyondspx.com/article/immucell-riding-operational-recovery-and-novel-technology-towards-profitability-iccc
0 · Reply
TagUrIt
TagUrIt Jul. 25 at 1:28 PM
$ICCC well the Zach’s announcement should help with the companies visibility…
1 · Reply
ZacksResearch
ZacksResearch Jul. 22 at 5:58 PM
$ICCC just got a major upgrade — here's why the bulls are circling 🐂 Q1 sales hit record highs, margins expanded, and Re-Tain’s FDA momentum plus new formats are fueling serious upside potential. Full breakdown of the upgrade here 👉 https://www.zacks.com/stock/news/2604144/immucell-upgraded-to-outperform-on-sales-surge-fda-upside?cid=sm-stocktwits-2-2604144-teaser-3177&ADID=SYND_STOCKTWITS_TWEET_2_2604144_TEASER_3177
0 · Reply
ZacksResearch
ZacksResearch Jul. 22 at 3:56 PM
$ICCC up 64.3% in a year — what's driving the surge? 🚀 📈 Record Q1 sales of $8.1M, up 11% YoY, fueled by strong First Defense demand. 📊 Gross margin jumped to 42% from 32% a year ago, boosting cash flow and liquidity. 🔍 New bulk powder format and the potential of Re-Tain under FDA review offer strategic growth opportunities. See what makes the investment case strong for ImmuCell 👉 https://www.zacks.com/stock/news/2604144/immucell-upgraded-to-outperform-on-sales-surge-fda-upside?cid=sm-stocktwits-2-2604144-body-3098&ADID=SYND_STOCKTWITS_TWEET_2_2604144_BODY_3098
0 · Reply
TommyTwenty
TommyTwenty Jul. 9 at 2:47 PM
$ICCC looks they’re initiating expansion from 30 mill to 40 mill.
0 · Reply
TommyTwenty
TommyTwenty Jul. 9 at 1:13 PM
$ICCC backlog has been reduced to under 100k.
0 · Reply
theRooster007
theRooster007 Jul. 9 at 12:41 PM
$ICCC https://lifesciencereport.com/news/nasdaq/iccc/immucell-announces-preliminary-unaudited-sales-results-for-q2-of-2025
0 · Reply
DARKP00L
DARKP00L Jul. 9 at 12:13 PM
$ICCC 08:11 on Jul. 09 2025 ImmuCell Announces Prelim. Q2 Sales $6.4M, Up 18% YoY #tradeideas
0 · Reply
TommyTwenty
TommyTwenty Jul. 2 at 8:19 PM
$ICCC recent selloffs have been low volume.
1 · Reply
TI7812
TI7812 Jun. 25 at 2:48 PM
$ICCC doubling position. The results of pivoting to contract manufacturing is making them very profitable after years of failing to get FDA approval for their in house production. So what on earth is wrong with CEO retiring? And retiring now that company is making a good profit? New CEO would only join to build on. We shall, added @ just under $6.00 "“I turn 65 this fall and have told my fellow Directors that I would like to retire from full-time work by early 2026,” said Michael F. Brigham, President and CEO. “I originally joined ImmuCell in 1989 and am very grateful to have had the opportunity to serve as the President and CEO of this growing Company since 2000.”
2 · Reply
JesterOfWallSt
JesterOfWallSt Jun. 25 at 2:39 PM
$CYCC 🚀🃏 Still have time to get in!! $NKTR $XBIO $ICCC
0 · Reply
_www_larval_com_
_www_larval_com_ Jun. 25 at 2:32 PM
$ICCC just sunk -13% lower to -7% (~171Kv) a few minutes ago, follow for more volatility.
0 · Reply
HaltTradeAlert
HaltTradeAlert Jun. 25 at 2:30 PM
$ICCC Halt Time: 10:29:04 Issue Symbol: ICCC Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
TommyTwenty
TommyTwenty Jun. 25 at 1:02 PM
$ICCC https://www.stocktitan.net/news/ICCC/immu-cell-embarks-on-ceo-succession-planning-8fvo1jbd8z62.html
1 · Reply
Doozio
Doozio Jun. 20 at 8:52 PM
$ICCC FRYday 🚀 bar
0 · Reply
TagUrIt
TagUrIt Jun. 20 at 8:43 PM
$ICCC nice. More big money coming into this stock!
0 · Reply
HaltTradeAlert
HaltTradeAlert Jun. 20 at 6:26 PM
$ICCC Halt Time: 14:23:57 Issue Symbol: ICCC Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
theRooster007
theRooster007 Jun. 13 at 5:28 PM
$ICCC insiders.. https://archive.fast-edgar.com/20250613/A22ZR22CLZ22O2AB22JR2CY2O8WTZ222ZG72/
0 · Reply
theRooster007
theRooster007 Jun. 13 at 5:27 PM
$ICCC insiders https://in.investing.com/news/insider-trading-news/immucell-director-bryan-gathagan-acquires-6320-in-shares-93CH-4874911
0 · Reply
TommyTwenty
TommyTwenty Jun. 12 at 2:23 PM
$ICCC talks of “partnership” are really heating up.
1 · Reply